Fexofenadine HCL
NDC 11673-767, Fexofenadine HCL, tablet, from TARGET CORPORATION.
- Product NDC
- 11673-767
- Status
- Listed
- Labeler
- TARGET CORPORATION
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA211075
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/11673-767 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FEXOFENADINE HYDROCHLORIDE180 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 11673-767-03 | 11673076703 | 30 TABLET in 1 BOTTLE (11673-767-03) |
| 11673-767-07 | 11673076707 | 15 TABLET in 1 BLISTER PACK (11673-767-07) |
| 11673-767-15 | 11673076715 | 150 TABLET in 1 BOTTLE (11673-767-15) |
| 11673-767-34 | 11673076734 | 70 TABLET in 1 BOTTLE (11673-767-34) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 11673-767 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/11673-767 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 11673-767. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.